iifl-logo-icon 1

Aarey Drugs & Pharmaceuticals Ltd Share Price

49.15
(-2.56%)
Jul 22, 2024|01:50:05 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open49.2
  • Day's High50
  • 52 Wk High68
  • Prev. Close50.44
  • Day's Low49
  • 52 Wk Low29.95
  • Turnover (lac)9.76
  • P/E27.27
  • Face Value10
  • Book Value47.18
  • EPS1.85
  • Mkt. Cap (Cr.)124.77
  • Div. Yield0
No Records Found

Aarey Drugs & Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

49.2

Prev. Close

50.44

Turnover(Lac.)

9.76

Day's High

50

Day's Low

49

52 Week's High

68

52 Week's Low

29.95

Book Value

47.18

Face Value

10

Mkt Cap (₹ Cr.)

124.77

P/E

27.27

EPS

1.85

Divi. Yield

0

Aarey Drugs & Pharmaceuticals Ltd Corporate Action

14 Aug 2023

12:00 AM

BookCloser

arrow

23 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

6 Dec 2023

12:00 AM

EGM

arrow

31 Jul 2023

12:00 AM

AGM

Announcement Date: 31 Jul, 2023

arrow

Aarey Drugs & Pharmaceuticals Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Aarey Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:18 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 45.27%

Foreign: 0.00%

Indian: 45.27%

Non-Promoter- 3.40%

Institutions: 3.39%

Non-Institutions: 51.32%

Custodian: 0.00%

Share Price

Aarey Drugs & Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

27.7

27.7

25.7

25.7

Preference Capital

0

0

0

0

Reserves

89.71

85.94

73.16

66.65

Net Worth

117.41

113.64

98.86

92.35

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

348.41

300.08

349.34

395.96

yoy growth (%)

16.1

-14.1

-11.77

60.94

Raw materials

-337.79

-290.18

-337.36

-382.98

As % of sales

96.95

96.69

96.56

96.72

Employee costs

-0.39

-0.39

-0.38

-0.33

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

8.3

7.24

8.19

7.97

Depreciation

-0.92

-0.89

-0.71

-0.64

Tax paid

-1.78

-1.44

-2.01

-2.5

Working capital

6.66

26.65

23.78

5.56

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

16.1

-14.1

-11.77

60.94

Op profit growth

43.51

-57.69

-20.51

848.64

EBIT growth

18.89

-10.71

-17.84

248.55

Net profit growth

12.44

-6.21

12.85

324.54

View Ratios

No Record found

Aarey Drugs & Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,568.65

123.313,76,323.69867.60.865,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,519.8

76.171,19,994.455310.662,259507.93

Cipla Ltd

CIPLA

1,485.5

32.291,19,928.541,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,144.45

33.511,15,173.541,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,636

25.851,10,759.071,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Aarey Drugs & Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Managing Director

Mihir R Ghatalia

Independent Director

Chetan K Mehta

Company Sec. & Compli. Officer

Preeti Paresh Rathi

Independent Director

Lalit Tulsiani

Executive Director

Nimit R Ghatalia

Independent Director

Anil Mandal

Additional Director

Bina Ghatalia

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Reports by Aarey Drugs & Pharmaceuticals Ltd

Summary

Aarey Drugs & Pharmaceuticals Ltd was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Pvt Ltd. The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana. In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the company and the company was converted into public limited company. Also, the name of the company was changed from Niharika Textiles & Chemicals Pvt Ltd to Aarey Drugs & Pharmaceuticals Ltd.The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, APIs Drugs, Food Colours and Flavours. The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business. Apart from the bulk drug manufacturing activity, they also undertake importing & distributing of various industrial chemicals & solvents throughout the country. The company has their manufacturing unit located at Thane.The companys products include Methyl Nitro Imidazole, Metronidazole & Metronidazole Benzoate. Their pharmaceutical products are sourced from the authentic vendors to assure the quality and effectiveness. The pharmaceutical products offered by the company are in compliance with IP/ BP/ CP/ USP standards. They have their registered office is located at Thane and their corporate office
Read More

Company FAQs

What is the Aarey Drugs & Pharmaceuticals Ltd share price today?

Down Arrow

The Aarey Drugs & Pharmaceuticals Ltd shares price on N/A is Rs.₹49.25 today.

What is the Market Cap of Aarey Drugs & Pharmaceuticals Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs & Pharmaceuticals Ltd is ₹125.02 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Aarey Drugs & Pharmaceuticals Ltd?

Down Arrow

The PE and PB ratios of Aarey Drugs & Pharmaceuticals Ltd is 27.27 and 0.98 as of 22 Jul ‘24

What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Aarey Drugs & Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aarey Drugs & Pharmaceuticals Ltd is ₹30 and ₹68 as of 22 Jul ‘24

What is the CAGR of Aarey Drugs & Pharmaceuticals Ltd?

Down Arrow

Aarey Drugs & Pharmaceuticals Ltd's CAGR for 5 Years at 25.35%, 3 Years at 10.25%, 1 Year at 50.42%, 6 Month at -9.43%, 3 Month at 7.34% and 1 Month at 7.27%.

What is the shareholding pattern of Aarey Drugs & Pharmaceuticals Ltd?

Down Arrow

The shareholding pattern of Aarey Drugs & Pharmaceuticals Ltd is as follows:
Promoters - 45.28 %
Institutions - 3.40 %
Public - 51.33 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.